Schedule 13G ownership disclosure

Entrada Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 29384C108

Event date: 2025-11-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TCG Crossover GP I, LLC

    Shares: 1,917,344 · Class: 5.0%

  • TCG Crossover Fund I, L.P.

    Shares: 1,917,344 · Class: 5.0%

  • Chen Yu

    Shares: 1,917,344 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-297315
Form type
SCHEDULE 13G
Filer
Entrada Therapeutics, Inc.
CIK
CIK 1689375
Filed
Nov 25, 2025
Reporting period
Nov 19, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub